Emerging systemic therapies for atopic dermatitis: biologics.
Kelsey B NusbaumCatherine M NguyenAlan B FleischerPublished in: The Journal of dermatological treatment (2020)
The growing class of biologics shows promise in meeting the needs of treatment-resistant atopic dermatitis. The use of validated core measurements is necessary for future trials in order to adequately compare agents and progress evidence-based medicine.